| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |